drugset / Trial / NCT00119119

Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C

NCT00119119

RandomizedParallel-groupDouble-blindTreatment

Summary

The fibrosis of liver is a complication of chronic hepatitis C. There is actually no established treatment for fibrosis of the liver. Pentoxyphilline and tocopherol may have an activity on fibrosis. The aim of the study is to analyse the efficacy and the safety of the combination with pentoxyphilline and tocopherol (12 months) on liver fibrosis, in patients with chronic hepatitis C, who are non-long-term responders, or with intolerance or contra-indication to interferon-alfa and ribavirin.

Timeline

Start
2002-02
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin E Other / unclassified 500 mg
Subject pentoxyphilline Unknown 400 mg